A bill to amend title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits.
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Mar 5, 2019)
This bill prohibits health insurers and contracted entities that provide pharmacy benefits management services from receiving a price reduction or other remuneration from prescription drug manufacturers. The prohibition does not apply if (1) the price reduction is reflected at the point-of-sale; and (2) the other remuneration is a transparent, flat service fee that the manufacturer pays in relation to pharmacy benefits management services.
What just happenedMar 5, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Who’s behind it
- Introduced in SenateMar 5, 2019
- Mar 5, 2019IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health, Education, Labor, and Pensions Committee - Mar 5, 2019IntroReferral10000
Introduced in Senate